Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of PEN 956.49 billion. The enterprise value is 1.08 trillion.

Market Cap	956.49B
Enterprise Value	1.08T

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	Mar 16, 2026

Share Statistics

Current Share Class	2.47B
Shares Outstanding	n/a
Shares Change (YoY)	-1.34%
Shares Change (QoQ)	-0.40%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	80.17%
Float	2.47B

Valuation Ratios

The trailing PE ratio is 15.58 and the forward PE ratio is 21.48.

PE Ratio	15.58
Forward PE	21.48
PS Ratio	4.37
PB Ratio	5.40
P/TBV Ratio	65.42
P/FCF Ratio	23.00
P/OCF Ratio	17.26
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.44, with an EV/FCF ratio of 26.05.

EV / Earnings	17.64
EV / Sales	4.74
EV / EBITDA	10.44
EV / EBIT	12.60
EV / FCF	26.05

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.96.

Current Ratio	1.54
Quick Ratio	0.96
Debt / Equity	0.96
Debt / EBITDA	1.71
Debt / FCF	4.09
Interest Coverage	18.03

Financial Efficiency

Return on equity (ROE) is 36.88% and return on invested capital (ROIC) is 25.91%.

Return on Equity (ROE)	36.88%
Return on Assets (ROA)	12.04%
Return on Invested Capital (ROIC)	25.91%
Return on Capital Employed (ROCE)	22.54%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	2.96M
Profits Per Employee	829,866
Employee Count	75,000
Asset Turnover	0.51
Inventory Turnover	2.32

Taxes

In the past 12 months, Merck & Co. has paid 9.43 billion in taxes.

Income Tax	9.43B
Effective Tax Rate	13.31%

Stock Price Statistics

The stock price has increased by +382.96% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+382.96%
50-Day Moving Average	118.28
200-Day Moving Average	99.57
Relative Strength Index (RSI)	19.82
Average Volume (20 Days)	6

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.48

Income Statement

In the last 12 months, Merck & Co. had revenue of PEN 218.71 billion and earned 61.41 billion in profits. Earnings per share was 24.49.

Revenue	218.71B
Gross Profit	168.87B
Operating Income	82.31B
Pretax Income	70.87B
Net Income	61.41B
EBITDA	97.92B
EBIT	82.31B
Earnings Per Share (EPS)	24.49

Balance Sheet

The company has 49.00 billion in cash and 170.01 billion in debt, giving a net cash position of -121.01 billion.

Cash & Cash Equivalents	49.00B
Total Debt	170.01B
Net Cash	-121.01B
Net Cash Per Share	n/a
Equity (Book Value)	177.17B
Book Value Per Share	71.52
Working Capital	51.10B

Cash Flow

In the last 12 months, operating cash flow was 55.42 billion and capital expenditures -13.83 billion, giving a free cash flow of 41.58 billion.

Operating Cash Flow	55.42B
Capital Expenditures	-13.83B
Depreciation & Amortization	16.23B
Net Borrowing	39.81B
Free Cash Flow	41.58B
FCF Per Share	n/a

Margins

Gross margin is 77.21%, with operating and profit margins of 37.64% and 28.08%.

Gross Margin	77.21%
Operating Margin	37.64%
Pretax Margin	32.41%
Profit Margin	28.08%
EBITDA Margin	44.77%
EBIT Margin	37.64%
FCF Margin	19.01%

Dividends & Yields

This stock pays an annual dividend of 11.53, which amounts to a dividend yield of 2.93%.

Dividend Per Share	11.53
Dividend Yield	2.93%
Dividend Growth (YoY)	-2.34%
Years of Dividend Growth	n/a
Payout Ratio	44.79%
Buyback Yield	1.34%
Shareholder Yield	4.27%
Earnings Yield	6.42%
FCF Yield	4.35%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 3.5 and a Piotroski F-Score of 5.

Altman Z-Score	3.5
Piotroski F-Score	5